Cerebral small vessel disease (SVD) is usually associated with high blood pressure, and causes 20% of all strokes. It is the main cause of cognitive changes and dementia associated with stroke. Behavioural symptoms such as apathy are also common in patients with SVD.
Professor Joanna Wardlaw CBE talks about the new SVDs@target programme - Targeting interventions for small vessel disease to prevent stroke and dementia. This programme was funded by a 6 million euro grant from the European Union’s Horizon 2020 programme.
Claris Diaz, 32, originally from California, now lives in Cardiff and has devoted her life to stroke research after her childhood was affected by stroke.
Evaluation of a new test to detect cognitive impairment in patients with small vessel disease stroke
Can we identify genetic risk factors that cause disease of small blood vessels in the brain?
The World Stroke Organization (WHO) reclassify stroke and vascular dementia for the next International Classification of Diseases (ICD).
Following a stroke, many treatments are recommended by health professionals, such as medications to prevent another stroke or physiotherapy to help limb weakness. Stroke survivors often have other chronic illnesses and report finding it difficult to follow treatments recommended by their doctors, nurses and therapists.
This fellowship will involve the study of the human eye to find out about the health of the brain’s small blood vessels and nerve connections in people who have recently had a stroke.
Development of new magnetic resonance imaging (MRI) techniques to image vessel patterns and blood flow in patients with disease of their vertebral arteries